COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 292: Articles 2911-2920  | Next

Identification of a Druggable Site on GRP78 at the GRP78-SARS-CoV-2 Interface and Compounds to Disrupt that Interface
Lazou, M., Hutton, J. R., Chakravarty, A., Joseph-McCarthy, D.
10.1101/2023.09.12.557363 — Posted: 2023-09-13
Infectious touching: Has COVID-19 changed our perceptions of social touch? A neural and behavioral study
Zoabi, D., Abado, E., Shamay-Tsoory, S., Peled-Avron, L.
10.1101/2023.09.12.557330 — Posted: 2023-09-13
Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
Lee, J., Zepeda, S., Park, Y.-J., Taylor, A. L., Quispe, J., Stewart, C., Leaf, E. M., Treichel, C., Corti, D., King, N. P., Starr, T. N., Veesler, D.
10.1101/2023.09.12.557371 — Posted: 2023-09-13
Navigating the Neurological Aftermath of COVID-19: An In-Depth Exploration
Butt, M., Nagpal, S., Phillips, E., Shah, S. Q., Dogar, Z., Loh, H., Mishra, S., Vijayan, R., Jeyakumar, R., Makkar, S. S., Jahan, S., Diaz, G. M., Franca, H., Javed, S., Belizaire, M.-P., Reddy Somagutta, M.
10.1101/2023.09.10.23295343 — Posted: 2023-09-12
Safety and immunogenicity of SW-BIC-213, a modified COVID-19 Lipo-Polyplex mRNA vaccine, in Laotian healthy adults aged 18 years and above: a Phase 1/2 trial
chen, y., li, j., Duangdany, D., Phamisith, C., bo, y., lan, s., Jin, L., Lv, D., li, y., luo, b., han, p., wu, j., wang, y., xu, c., shen, m., zhao, f., liu, p., pei, r., shen, H., guan, w., li, h., Mayxay, M.
10.1101/2023.09.11.23295344 — Posted: 2023-09-12
Finding Long-COVID: Temporal Topic Modeling of Electronic Health Records from the N3C and RECOVER Programs
O'Neil, S. T., Madlock-Brown, C., Wilkins, K. J., McGrath, B. M., Davis, H. E., Assaf, G. S., Wei, H., Zareie, P., French, E. T., Loomba, J., McMurry, J. A., Zhou, A., Chute, C. G., Moffitt, R. A., Pfaff, E. R., Yoo, Y. J., Leese, P., Chew, R. F., Lieberman, M., Haendel, M. A., N3C Consortium, , RECOVER Consortium
10.1101/2023.09.11.23295259 — Posted: 2023-09-12
Childhood maltreatment and subsequent risk of hospitalization or death due to COVID-19: a cohort study in the UK Biobank
Wang, Y., Ge, F., Aspelund, T., Ask, H., Hauksdottir, A., Hu, K., Jakobsdottir, J., Zoega, H., Shen, Q., Whalley, H. C., Pedersen, O. B. V., Lehto, K., Andreassen, O. A., Fang, F., Song, H., Valdimarsdottir, U. A.
10.1101/2023.09.12.23295354 — Posted: 2023-09-12
HEART rate variability biofeedback breathing programme for LOng Covid dysautonomia (HEARTLOC): results of a feasibility study
Corrado, J., Iftekhar, N., Halpin, S., Li, M., Tarrant, R., Grimaldi, J., Simms, A., O'Connor, R. J., Casson, A., Sivan, M.
10.1101/2023.09.09.23295208 — Posted: 2023-09-12
Sexual Gender-Based Violence among Adolescent Girls and Young Women during COVID-19 Pandemic, Mid-Eastern Uganda
Mwine, P., Kwesiga, B., Migisha, R., Cheptoris, J., Kadobera, D., Bulage, L., Nsubuga, E. J., Mudiope, P., Ario, A. R.
10.1101/2023.09.11.23295394 — Posted: 2023-09-12
Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections
Quirk, G., Schoenle, M. V., Peyton, K. L., Uhrlaub, J. L., Lau, B., Burgess, J., Ellingson, K., Beitel, S., Romine, J., Lutrick, K., Fowlkes, A., Britton, A., Tyner, H., Caban-Martinez, A., Naleway, A., Gaglani, M., Yoon, S., Edwards, L., Olsho, L., Dake, M. D., LaFleur, B., Nikolich, J. Z., Sprissler, R., Worobey, M., Bhattacharya, D.
10.1101/2023.09.12.23295384 — Posted: 2023-09-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).